Device Trial Radar · NCT07193888
Navitor Japan Study
Last checked: Nov 20, 2026Latest source record: May 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Oct 30, 2025
Primary completion
Jul 2028
Study completion Aug 2028
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Sep 26, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Navitor Japan Study is designed to evaluate the safety and performance of the Navitor™ valve used in combination with the FlexNav™ delivery system in a contemporary, real-world setting.
Conditions
- Severe Aortic Stenosis
Interventions
Navitor Transcatheter Aortic Valve ImplantationDevice
Subjects will undergo transcatheter aortic valve implantation (TAVI) with the Navitor valve, the FlexNav Delivery system and the Navitor Loading System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Safety EndpointTime frame: 30 days post index procedure
- Primary Performance EndpointTime frame: 30 days post index procedure
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Kokura Memorial Hospital
Fukuoka, Japan · Recruiting
Shonan Kamakura General Hospital
Kanagawa, Japan · Recruiting
Osaka Keisatsu Hospital
Osaka, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.